What is Citigroup's price target for BAX?

Citigroup's latest stated price target for Baxter International Inc. (BAX) is $28, from its action on Jul 31, 2026.

What is Citigroup's rating on BAX?

Citigroup rates BAX Neutral, a neutral rating, as of Jul 31, 2026.

When did Citigroup last change its view on BAX?

On Jul 31, 2026, Citigroup upgrades to Neutral from Sell, price target $28.

Citigroup BAX price target and rating history

Baxter International Inc. (BAX) · Health Care

Citigroup rates Baxter International Inc. (BAX) Neutral with a $28 price target, as of its latest action on Jul 31, 2026. It has published 4 rating actions on BAX since January 2022, including 1 upgrade and 2 downgrades.

Current rating: Neutral
Price target: $28
Median target, all firms: Too few
Actions on BAX: 4

Citigroup price target on BAX

Citigroup price target on BAX, each point a stated target, January 2022 to July 2026.

Every Citigroup rating on BAX

Jul 31, 2026
UpgradeCitigroup upgrades to Neutral from Sell, price target $28
May 28, 2026
DowngradeCitigroup downgrades to Sell from Neutral, price target $17
Dec 12, 2022
DowngradeCitigroup downgrades to Neutral from Buy, price target $64 to $58
Jan 7, 2022
ResumeCitigroup resumes coverage at Buy, price target $101

How other firms rate BAX

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Wolfe Research	Peer Perform		Oct 20, 2026
Barclays	Underweight	$20	Oct 7, 2026
Citigroup	Neutral	$28	Jul 31, 2026

Questions about Citigroup and BAX

What is Citigroup's price target for BAX?: Citigroup's latest stated price target for Baxter International Inc. (BAX) is $28, from its action on Jul 31, 2026.
What is Citigroup's rating on BAX?: Citigroup rates BAX Neutral, a neutral rating, as of Jul 31, 2026.
When did Citigroup last change its view on BAX?: On Jul 31, 2026, Citigroup upgrades to Neutral from Sell, price target $28.

More BAX rating histories

All Citigroup ratings BAX news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.